TENAX THERAPEUTICS, INC. Accrued Liabilities and Other Liabilities
TENAX THERAPEUTICS, INC. (TENX) had Accrued Liabilities and Other Liabilities of $815.86 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2019-04-01
- 2018-12-31: Accrued Liabilities and Other Liabilities $815.86K.
- 2018-09-30: Accrued Liabilities and Other Liabilities $104.30K.
- 2018-06-30: Accrued Liabilities and Other Liabilities $565.09K.
- 2018-03-31: Accrued Liabilities and Other Liabilities $100.78K.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2018-12-31 | $815.86K 10-K · filed 2019-04-01 |
| 2018-09-30 | $104.30K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $565.09K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $100.78K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $363.31K 10-K · filed 2019-04-01 |
| 2017-09-30 | $223.09K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.68M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.58M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.25M 10-K · filed 2018-04-02 |
| 2016-09-30 | $3.35M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.39M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.83M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.10M 10-K · filed 2017-03-16 |
| 2015-10-31 | $2.54M 10-Q · filed 2015-12-10 |
| 2015-07-31 | $1.92M 10-Q · filed 2015-09-09 |
| 2015-04-30 | $2.66M 10-KT · filed 2016-03-14 |
| 2015-01-31 | $1.71M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $1.30M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $612.82K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $858.14K 10-KT · filed 2016-03-14 |
| 2014-01-31 | $1.49M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $322.44K 10-Q · filed 2013-12-17 |
| 2013-07-31 | $319.32K 10-Q · filed 2013-09-17 |
| 2013-04-30 | $874.88K 10-K · filed 2014-07-29 |
| 2013-01-31 | $1.09M 10-Q · filed 2013-03-18 |
| 2012-10-31 | $428.82K 10-Q · filed 2012-12-14 |
| 2012-07-31 | $1.11M 10-Q · filed 2012-09-19 |
| 2012-04-30 | $1.27M 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |